Changes in the Expression of MexB, MexY, and OprD in Clinical Pseudomonas Aeruginosa Isolates

Overview

Journal Proc Jpn Acad Ser B Phys Biol Sci

Specialties Biology
Science

Date 2024 Jan 10

PMID 38199247

Authors

Yoshimi Matsumoto

Seiji Yamasaki

Kouhei Hayama

Ryota Iino

Hiroyuki Noji

Akihito Yamaguchi

Kunihiko Nishino

Affiliations

Soon will be listed here.

Abstract

Changes in expression levels of drug efflux pump genes, mexB and mexY, and porin gene oprD in Pseudomonas aeruginosa were investigated in this study. Fifty-five multidrug-resistant P. aeruginosa (MDRP) strains were compared with 26 drug-sensitive strains and 21 strains resistant to a single antibiotic. The effect of the efflux inhibitor Phe-Arg-β-naphthylamide on drug susceptibility was determined, and gene expression was quantified using real-time quantitative real-time reverse transcription polymerase chain reaction. In addition, the levels of metallo-β-lactamase (MBL) and 6'-N-aminoglycoside acetyltransferase [AAC(6')-Iae] were investigated. Efflux pump inhibitor treatment increased the sensitivity to ciprofloxacin, aztreonam, and imipenem in 71%, 73%, and 29% of MDRPs, respectively. MBL and AAC(6')-Iae were detected in 38 (69%) and 34 (62%) MDRP strains, respectively. Meanwhile, 76% of MDRP strains exhibited more than 8-fold higher mexY expression than the reference strain PAO1. Furthermore, 69% of MDRP strains expressed oprD at levels less than 0.01-fold of those in PAO1. These findings indicated that efflux pump inhibitors in combination with ciprofloxacin or aztreonam might aid in treating MDRP infections.

References

Mesaros N, Nordmann P, Plesiat P, Roussel-Delvallez M, Van Eldere J, Glupczynski Y . Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect. 2007; 13(6):560-78. DOI: 10.1111/j.1469-0691.2007.01681.x. View

Nordmann P, Poirel L . Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect. 2002; 8(6):321-31. DOI: 10.1046/j.1469-0691.2002.00401.x. View

Kirikae T, Mizuguchi Y, Arakawa Y . Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan. J Antimicrob Chemother. 2008; 61(3):612-5. DOI: 10.1093/jac/dkm537. View

Kimura S, Ishii Y, Yamaguchi K . Evaluation of dipicolinic acid for detection of IMP- or VIM- type metallo-beta-lactamase-producing Pseudomonas aeruginosa clinical isolates. Diagn Microbiol Infect Dis. 2005; 53(3):241-4. DOI: 10.1016/j.diagmicrobio.2005.05.017. View

Chevalier S, Bodilis J, Jaouen T, Barray S, Feuilloley M, Orange N . Sequence diversity of the OprD protein of environmental Pseudomonas strains. Environ Microbiol. 2007; 9(3):824-35. DOI: 10.1111/j.1462-2920.2006.01191.x. View

Kitao T, Miyoshi-Akiyama T, Shimada K, Tanaka M, Narahara K, Saito N . Development of an immunochromatographic assay for the rapid detection of AAC(6')-Iae-producing multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother. 2010; 65(7):1382-6. DOI: 10.1093/jac/dkq148. View

Akasaka T, Tanaka M, Yamaguchi A, Sato K . Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother. 2001; 45(8):2263-8. PMC: 90640. DOI: 10.1128/AAC.45.8.2263-2268.2001. View

Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Fujino T, Kobayashi I, Morita K . Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(6')-Iae gene cassette encoding a novel aminoglycoside acetyltransferase. Antimicrob Agents Chemother. 2005; 49(9):3734-42. PMC: 1195402. DOI: 10.1128/AAC.49.9.3734-3742.2005. View

Giske C, Buaro L, Sundsfjord A, Wretlind B . Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa. Microb Drug Resist. 2008; 14(1):23-30. DOI: 10.1089/mdr.2008.0778. View

10.

Pages J, James C, Winterhalter M . The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol. 2008; 6(12):893-903. DOI: 10.1038/nrmicro1994. View

11.

Yoneda K, Chikumi H, Murata T, Gotoh N, Yamamoto H, Fujiwara H . Measurement of Pseudomonas aeruginosa multidrug efflux pumps by quantitative real-time polymerase chain reaction. FEMS Microbiol Lett. 2005; 243(1):125-31. DOI: 10.1016/j.femsle.2004.11.048. View

12.

Wagner V, Iglewski B . P. aeruginosa Biofilms in CF Infection. Clin Rev Allergy Immunol. 2008; 35(3):124-34. DOI: 10.1007/s12016-008-8079-9. View

13.

Nakajima A, Sugimoto Y, Yoneyama H, Nakae T . High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation. Microbiol Immunol. 2002; 46(6):391-5. DOI: 10.1111/j.1348-0421.2002.tb02711.x. View

14.

Ochs M, McCusker M, Bains M, Hancock R . Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob Agents Chemother. 1999; 43(5):1085-90. PMC: 89115. DOI: 10.1128/AAC.43.5.1085. View

15.

Schweizer H . Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res. 2003; 2(1):48-62. View

16.

Ryan B, Dougherty T, Beaulieu D, Chuang J, Dougherty B, Barrett J . Efflux in bacteria: what do we really know about it?. Expert Opin Investig Drugs. 2002; 10(8):1409-22. DOI: 10.1517/13543784.10.8.1409. View

17.

Aoki N, Tateda K, Kikuchi Y, Kimura S, Miyazaki C, Ishii Y . Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother. 2009; 63(3):534-42. DOI: 10.1093/jac/dkn530. View

18.

Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis A, Pournaras S . A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. J Antimicrob Chemother. 2007; 60(1):132-5. DOI: 10.1093/jac/dkm126. View

19.

Nikaido H . Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science. 1994; 264(5157):382-8. DOI: 10.1126/science.8153625. View

20.

Mesaros N, Glupczynski Y, Avrain L, Caceres N, Tulkens P, Van Bambeke F . A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa. J Antimicrob Chemother. 2007; 59(3):378-86. DOI: 10.1093/jac/dkl504. View